Janney Montgomery Scott LLC Buys 2,668 Shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Janney Montgomery Scott LLC grew its stake in BlackRock Health Sciences Term Trust (NYSE:BMEZFree Report) by 9.7% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 30,163 shares of the company’s stock after acquiring an additional 2,668 shares during the quarter. Janney Montgomery Scott LLC’s holdings in BlackRock Health Sciences Term Trust were worth $449,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of BMEZ. Saba Capital Management L.P. raised its holdings in BlackRock Health Sciences Term Trust by 0.4% in the 4th quarter. Saba Capital Management L.P. now owns 20,750,913 shares of the company’s stock worth $298,813,000 after acquiring an additional 89,523 shares during the last quarter. Sit Investment Associates Inc. increased its holdings in shares of BlackRock Health Sciences Term Trust by 7.9% in the 4th quarter. Sit Investment Associates Inc. now owns 1,724,706 shares of the company’s stock worth $24,836,000 after purchasing an additional 125,599 shares in the last quarter. Invesco Ltd. raised its stake in shares of BlackRock Health Sciences Term Trust by 0.8% in the fourth quarter. Invesco Ltd. now owns 1,543,745 shares of the company’s stock worth $22,230,000 after purchasing an additional 11,684 shares during the last quarter. Bank of America Corp DE lifted its holdings in shares of BlackRock Health Sciences Term Trust by 10.9% during the fourth quarter. Bank of America Corp DE now owns 1,355,347 shares of the company’s stock valued at $19,517,000 after purchasing an additional 132,926 shares in the last quarter. Finally, Raymond James Financial Inc. purchased a new stake in shares of BlackRock Health Sciences Term Trust during the fourth quarter valued at $10,869,000.

BlackRock Health Sciences Term Trust Trading Down 0.1%

NYSE BMEZ opened at $14.46 on Friday. BlackRock Health Sciences Term Trust has a one year low of $12.58 and a one year high of $16.75. The stock has a 50-day moving average of $14.43 and a 200 day moving average of $14.90.

BlackRock Health Sciences Term Trust Cuts Dividend

The business also recently declared a monthly dividend, which will be paid on Thursday, July 31st. Stockholders of record on Tuesday, July 15th will be issued a dividend of $0.1672 per share. This represents a $2.01 dividend on an annualized basis and a dividend yield of 13.88%. The ex-dividend date of this dividend is Tuesday, July 15th.

BlackRock Health Sciences Term Trust Company Profile

(Free Report)

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.

Further Reading

Institutional Ownership by Quarter for BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.